Experiences with
Lymphomas789 public posts
Want to take advantage of all our features? Just log in!
or
CRISPR gene-editing tested in a person for the first time, treating aggressive lung cancer
[i]'A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique.[/i]
[i]On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer
CLL Research Down Under into BTK cardiotoxicity, e.g. development of AF on Ibrutinib - from CLL Global Research Foundation
From the CLL Global Research Foundation - October / November Issue
[i]'Earlier this year CLL Global was approached by a donor interested in making a contribution that would be directed specifically towards research into cardiotoxicity associated with Bruton's tyrosine kinase (BTK) inhibitors such as
Follicular Lymphoma Patient Survey
If you have follicular lymphoma and have been treated with obinituzumab (Gazyva) you can help by completing our survey.
Lymphoma Canada is preparing a submission for the panCanadian Oncology Drug Review (pCODR) for:
Obinituzumab in combination with chemotherapy, followed by obinutuzumab maintenance